Launch of the Global Health Security Agenda

Mar 20, 2014 | Sara Rubin

By Sara Rubin, MPH, MA, Senior Program Analyst, Pandemic & Catastrophic Preparedness, NACCHO, and Lilly Kan, MPH, Senior Program Anlayst, Infectious Disease, NACCHO

On Friday, Feb. 21, two NACCHO preparedness and infectious disease staff attended the
Launch of the Global Health Security (GHS) Agenda,
a briefing hosted by the UPMC Center for Health Security, the Center for Strategic and International Studies (CSIS), Connecting Organizations for Regional Disease Surveillance, Nuclear Threat Initiative (NTI), and the American Association for the Advancement of Science (AAAS). The purpose of this briefing was to bring together a broader, more diverse set of stakeholders to provide background on the GHS Agenda and discuss the role of non-governmental organizations, the scientific, technology, and academic communities, and security sector in implementing the GHS Agenda.

J. Stephen Morrison (Senior Vice President and Global Health Policy Director, CSIS) moderated the briefing. Speakers included:

  • Dr. Tom Frieden – Director, Centers for Disease Control and Prevention (CDC);
  • Laura Holgate – Senior Director for Weapons of Mass Destruction Terrorism and Threat Reduction, National Security Council;
  • Deborah Rosenblum – Executive Vice President, NTI;
  • Tom Inglesby – Chief Executive Officer and Director, UPMC Center for Health Security; and
  • Kavita Berger – Associate Director, Center for Science, Technology, and Security Policy, AAAS.

Several key messages resonated with NACCHO staff throughout the meeting, including how best to define the effort. According to the speakers, the GHS Agenda is:

  • Not a new initiative, but rather a framework that shines light on biosecurity and biosafety efforts that have been ongoing for years;
  • Meant to be a specific concept and has nine objectives that fall within the three basic areas: prevent, detect, and respond;
  • Complements the International Health Regulations (IHRs), the G-8, and other existing international bodies, rather than creating competing priorities;
  • Intended to raise the political visibility and incite a call to action across the world through a diverse group of stakeholders;
  • A mechanism to streamline federal efforts, reduce duplication, and align existing or provide new resources to address threats globally in a dedicated manner;
  • An approach that stresses measurable progress, but will require the development of new metrics and targets; and
  • Explained first through stories that convey the ongoing and re-emerging infectious disease threats (e.g. severe acute respiratory syndrome [SARS], H7N9) and how we can build upon those lessons learned.

Dr. Frieden told the audience when conveying the GHS Agenda to others, the fundamental message needs to be, “safer country, safer world.” He highlighted and compared SARS, other corovnaviruses, and measles as examples of global health threats and the improvements in technology (e.g. cheaper sequencing) and efforts (e.g. vaccination campaigns) that have improved prevention, detection, and response. Furthermore, he emphasized that the GHS Agenda is not intended to be a vague concept, but is rather one that focuses on three risks, three opportunities, and three priorities:

Risks Opportunities Priorities
1. Emerging organisms
2. Drug resistance
3. Intentional creation
1. Societal commitment
2. New technologies
3. Success leads to success
1. Prevent whenever possible (i.e. immunize)
2. Detect rapidly
3. Respond effectively

As an example of work the CDC is doing to improve disease detection and response, Frieden referred to a pilot project in Uganda. “By building strong global health security systems, we can improve health systems more generally,” Frieden said. Throughout his remarks, Frieden also expressed the need to increase GHS workforce, take a multi-sectoral approach, leverage technology in diagnostics (e.g., dipstick testing) and organization (e.g. video conferencing), and look for innovations and support them.

p0130-us-safer-2sm

Laura Holgate indicated the GHS Agenda is “not some new strategy, but builds on existing work.” She tied the nine objectives back the IHRs and expressed that the GHS Agenda is meant to support the IHRs. Holgate also discussed that while the objectives are not quantitative, the White House will be looking to partners to develop metrics and indicators of success. A goal for the GHS Agenda is to “get to the point where outbreaks are recorded in real-time,” according to Holgate. She also mentioned the vital role for the NGO sector in GHS.

NACCHO staff also attended an NGO partners meeting on March 13 that the AAAS Center for Science, Technology, and Security Policy convened to discuss the roles that NGOs have in helping to achieve the objectives of the GHS Agenda. The partners, who represented public health, biosafety, biosecurity, academic, foundation, veterinary, and other global health sectors, explored opportunities and needs that the group could collectively address to advance the GHS Agenda. AAAS is summarizing the meeting discussion and determining next steps.

NACCHO has, on occasion, engaged in international dialogue and facilitated efforts to connect local health departments with international local public health agencies to share experiences and lessons learned around public health issues. The GHS Agenda offers new momentum and opportunities for NACCHO to build new and strengthen existing relationships with partners across the globe. NACCHO welcomes local health departments to share ideas and perspectives as it continues to expand its GHS portfolio. Read our prior blog post about the GHS Agenda to learn more.

As a local health department, has your agency engaged in addressing global health? How do you think local health departments could better connect with international public health agencies?


About Sara Rubin

More posts by Sara Rubin

Related Posts

Doctor 563428 640
  • COVID-19
  • Health in All Policies
  • Leadership
  • Workforce Development

Preparing Your Local Health Department for the Future

If the pandemic has taught us one thing, it is the importance of preparedness....

Jan 15, 2021 | Guest Author

Preparing Your Local Health Department for the Future

Covid
  • COVID-19
  • Immunization

Dosing intervals for COVID-19 mRNA Vaccine

On January 6, CDC revised Interim Clinical Considerations for Use of mRNA...

Jan 14, 2021 | Beth Hess

Dosing intervals for COVID-19 mRNA Vaccine

  • Opportunity

APHA 2021 Call for Abstracts is Open

Submit an abstract to present and share research with public health leaders and...

Jan 13, 2021 | Anu Varma

APHA 2021 Call for Abstracts is Open

CRC Sim PLER
  • Webinar
  • Emergency Response

CRC SimPLER: A Practice Workshop

To introduce CRC SimPLER, ASTHO and the National Alliance for Radiation...

Jan 11, 2021 | Beth Hess

CRC SimPLER: A Practice Workshop

Coronavirus COVID 19
  • COVID-19
  • Tools & Resources
  • Epidemiology

COVID-19 Genomic Epidemiology Toolkit

The CDC Office of Advanced Molecular Detection (AMD) recently released the...

Jan 11, 2021 | Beth Hess

COVID-19 Genomic Epidemiology Toolkit

Covid
  • COVID-19
  • Webinar

NACCHO COVID-19 Webinar: Increasing Vaccination Coverage...

NACCHO invites local health department leadership and staff to join the...

Jan 08, 2021 | Beth Hess

NACCHO COVID-19 Webinar: Increasing Vaccination Coverage...

Webinar
  • COVID-19
  • Webinar

NACCHO COVID-19 Webinar: Understanding Diverse...

NACCHO invites local health department leadership and staff to join the...

Jan 08, 2021 | Beth Hess

NACCHO COVID-19 Webinar: Understanding Diverse...

Needleexchange 0
  • HIV, STI, & Viral Hepatitis

Join NACCHO’s SSP Monitoring & Evaluation Advisory Group

The National Association of County and City Health Officials (NACCHO), in...

Jan 07, 2021 | Kat Kelley

Join NACCHO’s SSP Monitoring & Evaluation Advisory Group

Orange County
  • COVID-19
  • Immunization

Orange County, NY, administers 800 COVID-19 Vaccines in...

Orange County, NY received 800 doss of the Moderna COVID-19 vaccine the morning...

Jan 07, 2021 | Beth Hess

Orange County, NY, administers 800 COVID-19 Vaccines in...

Back to Top